Clinical Trial Update: Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention of catheter-related bloodstream infection in patients with hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Centre National de Greffe de Moelle Osseuse | Conditions: Infection | Phase 3 | Status: COMPLETED